| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 06/16/2004 | CN1504460A Bulk dyeing using quinophthalone dyestuffs |
| 06/16/2004 | CA2465554A1 Quinoline derivatives as probes for the diagnosis of diseases in which tau protein accumulates |
| 06/15/2004 | US6750348 Protective effects against infection by hiv through binding to chemokine receptors, including cxcr4 and ccr5;n-(2-pyridinylmethyl)-n'-(2-(phenylureido)ethyl)-n'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine |
| 06/15/2004 | US6750255 Calcium receptor-active compounds |
| 06/15/2004 | US6750233 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 06/15/2004 | US6750218 Inhibitory activity on phosphorylation of platelet-derived growth factor (pdgf) receptor useful for the treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis |
| 06/15/2004 | US6750214 Quinoline and quinazoline compounds useful in therapy |
| 06/15/2004 | US6750183 Crankcase lubricants providing improved performance, including improved soot dispersancy |
| 06/10/2004 | WO2004048338A1 Noncyclic 1,3-dicarbonyl compounds as dual ppar agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/10/2004 | WO2004048314A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 06/10/2004 | WO2004047538A1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides |
| 06/10/2004 | WO2004018429A3 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/10/2004 | WO2004016578A3 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110808 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/10/2004 | US20040110806 Dipeptide derivatives |
| 06/10/2004 | US20040110767 Acyclic amide and sulfonamide ligands for the estrogen receptor |
| 06/10/2004 | US20040110762 inhibitors of protein tyrosine kinase and are antiproliferative agents; 4-(4-phenoxyanilino)benzo[g]quinoline-3-carbonitrile for example; chemical intermediates, synthesis; treating polycystic kidney disease, colon polyps, cancer |
| 06/10/2004 | US20040110753 Tyrosine derivatives |
| 06/10/2004 | US20040110745 Serotonin (5-HT) receptor antagonists; psychiatric, eating , sexual, panic, psychological, gastrointestinal, cardiovascular, and sleep disorders; headaches, dementia |
| 06/10/2004 | US20040110031 emits a blue light with high emission luminance, high quantum efficiency and long half life and a display employing the organic element |
| 06/10/2004 | US20040108507 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/10/2004 | CA2507458A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 06/10/2004 | CA2502183A1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides |
| 06/09/2004 | EP1426360A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 06/09/2004 | EP1426046A1 Novel use of tricyclic compound |
| 06/09/2004 | EP1425287A1 Processes for preparing calcium salt forms of statins |
| 06/09/2004 | EP1425270A2 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
| 06/09/2004 | EP1100795B1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1502609A Process for synthesizing inhibitor of phosphatidase A2 |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747043 Alkoxy aryl β2 adrenergic receptor agonists |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004045651A1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils |
| 06/03/2004 | WO2004045614A1 Quinoline derivatives as glucokinase ligands |
| 06/03/2004 | WO2004033418A3 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 06/03/2004 | WO2004022542A3 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106675 class of compounds generally called the "statins" for use in stimulating bone formation and method to identify compounds useful in this regard by assessing their ability to inhibit enzymes in the pathway of isoprenoid synthesis |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106611 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106007 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/02/2004 | EP1424382A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/02/2004 | EP1114032B1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/02/2004 | CN1501919A Quinoline derivatives and their use as antibiotics |
| 06/02/2004 | CN1501918A Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 06/02/2004 | CN1152015C Piperazine devivatives and preparing method thereof |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743804 Quinoline derivatives as NK3 antagonists |
| 05/27/2004 | WO2004043930A1 Quinoline derivatives which enhance cognition via the gaba-a receptor |
| 05/27/2004 | WO2004043911A2 N-cycloalkylglycines as hiv protease inhibitors |
| 05/27/2004 | WO2004043496A1 Fluorquinolines labelled with fluorine-18 |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | WO2004043362A2 Acyl guanidine compounds and use thereof |
| 05/27/2004 | WO2004043355A2 Alpha, alpha-disubstituted benzylglycine derivatives as hiv protease inhibitors |
| 05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 05/27/2004 | WO2003000295A3 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102491 Antimicrobial agents |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders |
| 05/27/2004 | US20040100188 Anthracene derivative and organic electroluminescence device using the derivative |
| 05/27/2004 | US20040099609 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/26/2004 | EP1421061A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 05/26/2004 | EP1420644A1 Substituted propargylamines |
| 05/26/2004 | EP1137645B1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 05/26/2004 | EP1117661B1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | CN1500079A Method for preparing 7-quinolinyl-3, 5-dihydroxyhept-6-enoate |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/26/2004 | CN1151151C Method for producing f-methoxy-quinoline carboxylic acids |
| 05/25/2004 | US6740758 Reacting p-anisidine with 3-chloropropionyl chloride in presence of sodium bicarbonate and toluene and cyclizing |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/25/2004 | CA2267059C Sordarin derivatives |
| 05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
| 05/21/2004 | WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041818A1 Anti-infective agents |
| 05/21/2004 | WO2004041802A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041801A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041787A1 Process for producing quinolinecarbaldehyde |
| 05/21/2004 | WO2004041210A2 Antibacterial agents |
| 05/21/2004 | WO2004041151A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 05/21/2004 | WO2004022528A3 Arylglycine derivatives and their use as glycine transport inhibitors |
| 05/21/2004 | WO2004014860A3 Fused heterocyclic compounds as peptidase inhibitors |
| 05/21/2004 | CA2505476A1 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 05/21/2004 | CA2505239A1 Process for producing quinolinecarbaldehyde |